IMR Press / FBL / Special Issues / molecular_research_breast_cancer

Molecular Research for Breast Cancer

Submission deadline: 31 January 2023
Special Issue Editor
  • Shih-Min Hsia, PhD
    School of Nutrition and Health Sciences, Taipei Medical University, Taiwan
    Interests: nutrition; food sciences; nutraceutical; dietary supplemants; dysmenorrhea; endometriosis; female cancers; uterine leiomyoma
    Special Issues and Topics in IMR Press journals
Special Issue Information

Dear Colleagues,

The incidence and mortality of breast cancer rank first among gynecological tumors worldwide. Early detection, timely diagnosis and tailored management have become critical steps in the treatment of breast cancer. Many studies have used chemotherapeutics or molecularly targeted therapy to reduce cancer progression by targeting specific mutated genes in breast cancer patients along with consideration of the factors that make breast cancer worse. However, there are many patients whose therapeutic effects are mitigated due to adverse reactions from side effects of the drugs utilized. Natural products can assist current chemotherapeutic agents and achieve therapeutic effects at lower doses. Advantages are not only to inhibit the growth of malignant tumors at a dose that is harmless to normal tissues, but also to improve many symptoms derived from the disease in combination with the efficacy of the natural products themselves. Therefore, exploring the molecular mechanism of adjuvant therapy using various natural products is the focus of this special topic.

This Special Issue encourages interested researchers to provide abstracts and ensure compliance with the scope of this issue before submitting manuscripts.

This Special Issue will cover topics including:

-    The efficacy of natural products on breast cancer
-    The impact of nutrients on breast cancer treatment
-    Molecular mechanisms involved in the treatment of breast cancer with natural products
-    Molecular mechanism of natural products for adjuvant chemotherapeutics

Prof. Shih-Min Hsia

Guest Editor

Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (2 Papers)
Back to top